Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death

BACKGROUND: Chronic graft-versus-host disease (cGVHD) is a serious complication of allogeneic hematopoietic cell transplantation (HCT). More accurate information regarding the risk of developing cGVHD is required. Bone marrow (BM) grafts contribute to lower cGVHD, which creates a dispute over whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Logan, Brent R., Fu, Denggang, Howard, Alan, Fei, Mingwei, Kou, Jianqun, Little, Morgan R., Adom, Djamilatou, Mohamed, Fathima A., Blazar, Bruce R., Gafken, Philip R., Paczesny, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378149/
https://www.ncbi.nlm.nih.gov/pubmed/37526081
http://dx.doi.org/10.1172/JCI168575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378149/
https://www.ncbi.nlm.nih.gov/pubmed/37526081
http://dx.doi.org/10.1172/JCI168575

Ejemplares similares